REGENERON PHARMACEUTICALS, INC. (REGN) Operating Lease, Liability, Current USD 2022 - 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary: Regeneron Pharmaceuticals, Inc. quarterly Operating Lease, Liability, Current history and growth rate from 2022 to 2023.
Regeneron Pharmaceuticals, Inc. Operating Lease, Liability, Current for the quarter ending December 31, 2023 was $19M, a 53.2% increase year-over-year.

Operating Lease, Liability, Current, Quarterly Data (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$19M	+$6.6M	+53.2%	Dec 31, 2023	10-K	2024-02-05
Q4 2022	$12.4M			Dec 31, 2022	10-K	2024-02-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.